Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

AIMS: Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in double-blind, randomized, placebo-controlled trials. METHODS AND RESULTS:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Heart J
Asıl Yazarlar: Cleland, John G F, Bunting, Karina V, Flather, Marcus D, Altman, Douglas G, Holmes, Jane, Coats, Andrew J S, Manzano, Luis, McMurray, John J V, Ruschitzka, Frank, van Veldhuisen, Dirk J, von Lueder, Thomas G, Böhm, Michael, Andersson, Bert, Kjekshus, John, Packer, Milton, Rigby, Alan S, Rosano, Giuseppe, Wedel, Hans, Hjalmarson, Åke, Wikstrand, John, Kotecha, Dipak
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Fast Track Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837435/
https://ncbi.nlm.nih.gov/pubmed/29040525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx564
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller